-
Loading metrics
Open Access
Peer-reviewed
Research Article
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy
-
Anthony Sinadinos,
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Christopher N. J. Young ,
Contributed equally to this work with: Christopher N. J. Young, Rasha Al-Khalidi, Léonore Floriot, Tiphaine Henry
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Rasha Al-Khalidi ,
Contributed equally to this work with: Christopher N. J. Young, Rasha Al-Khalidi, Léonore Floriot, Tiphaine Henry
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Anna Teti,
Affiliation Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
⨯ -
Paweł Kalinski,
Affiliation Departments of Surgery, Immunology, and Bioengineering, School of Medicine, University of Pittsburgh, Pittsburg, Pennsylvania, United States of America
⨯ -
Shafini Mohamad,
Affiliation School of Engineering, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Léonore Floriot ,
Contributed equally to this work with: Christopher N. J. Young, Rasha Al-Khalidi, Léonore Floriot, Tiphaine Henry
Affiliation Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France
⨯ -
Tiphaine Henry ,
Contributed equally to this work with: Christopher N. J. Young, Rasha Al-Khalidi, Léonore Floriot, Tiphaine Henry
Affiliation Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France
⨯ -
Gianluca Tozzi,
Affiliation School of Engineering, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Taiwen Jiang,
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Olivier Wurtz,
Affiliation INSERM U982, Plate-Forme d’Imagerie PRIMACEN, IRIB, University of Rouen, Mont-Saint-Aignan, France
⨯ -
Alexis Lefebvre,
Affiliation Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France
⨯ -
Mikhail Shugay,
Affiliation Genomics of Adaptive Immunity Lab, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry and Pirogov Russian National Research Medical University, Moscow, Russia
⨯ -
Jie Tong,
Affiliation School of Engineering, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
David Vaudry,
Affiliation INSERM U982, Plate-Forme d’Imagerie PRIMACEN, IRIB, University of Rouen, Mont-Saint-Aignan, France
⨯ -
Stephen Arkle,
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ -
Jean-Claude doRego,
Affiliations Platform of Behavioural Analysis (SCAC), University of Rouen, Mont-Saint-Aignan,Rouen, France, National Center of Scientific Research (CNRS), Caen, France
⨯ - [ ... ],
-
Dariusz C. Górecki
* E-mail: darek.gorecki@port.ac.uk
Affiliation Molecular Medicine, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
⨯ - [ view all ]
- [ view less ]
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy
- Anthony Sinadinos,
- Christopher N. J. Young,
- Rasha Al-Khalidi,
- Anna Teti,
- Paweł Kalinski,
- Shafini Mohamad,
- Léonore Floriot,
- Tiphaine Henry,
- Gianluca Tozzi,
- Taiwen Jiang
- Published: October 13, 2015
- https://doi.org/10.1371/journal.pmed.1001888